John Keane (@keane_jpm) 's Twitter Profile
John Keane

@keane_jpm

Consultant Urologist University Hospital Waterford and UPMC Aut Even

ID: 1286675138

calendar_today21-03-2013 18:43:02

226 Tweet

199 Takipçi

650 Takip Edilen

Marcus Drake (@marcusdrakeurol) 's Twitter Profile Photo

AT LAST, we can accurately advise men likely result of prostate surgery for urinary symptoms. This Eur Urol Focus paper is the UPSTREAM model for how EAU guidelines clinic tests predict outcome. The algorithm gives patients best chance of improving. authors.elsevier.com/sd/article/S24….

AT LAST, we can accurately advise men likely result of prostate surgery for urinary symptoms. This <a href="/EurUrolFocus/">Eur Urol Focus</a> paper is the UPSTREAM model for how <a href="/EauGuidelines/">EAU guidelines</a> clinic tests predict outcome. The algorithm gives patients best chance of improving. 
 authors.elsevier.com/sd/article/S24….
Univ Hosp Waterford (@uhw_waterford) 's Twitter Profile Photo

UHW are currently recruiting for a Clinical Nurse Specialist (Urology). Please click on the link below for further information. #Recruiting #JobAlert #JobVacancies #HSE #SSWHG #UHW rezoomo.com/job/59553/

John Keane (@keane_jpm) 's Twitter Profile Photo

Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial - ScienceDirect sciencedirect.com/science/articl…

John Keane (@keane_jpm) 's Twitter Profile Photo

Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a U.S. FDA pooled analysis academic.oup.com/jnci/article/d…

John Keane (@keane_jpm) 's Twitter Profile Photo

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma | New England Journal of Medicine nejm.org/doi/full/10.10…

Tom Powles (@tompowles1) 's Twitter Profile Photo

Perioperative durvalumab + neoadjuvant chemo & cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024 NEJM

Perioperative durvalumab + neoadjuvant chemo &amp; cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024  <a href="/NEJM/">NEJM</a>
Urology Times (@urologytimes) 's Twitter Profile Photo

Transperineal biopsy lowers the risk of infectious complications while maintaining a similar rate of prostate cancer detection compared with transrectal biopsy, according to data from the PREVENT trial. Jim Hu Edward Schaeffer, MD, PhD Weill Cornell Medicine Urology NM Urology urologytimes.com/view/prevent-t…

NEJM (@nejm) 's Twitter Profile Photo

In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: nej.md/4dBI8UN

In patients with muscle-invasive bladder cancer, extended lymphadenectomy did not improve disease-free or overall survival as compared with the standard procedure and was associated with higher morbidity and mortality. Full SWOG S1011 trial results: nej.md/4dBI8UN
Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer🚨 👏Landmark trial in urology in NEJM 😷592 patients randomized 🗓️Median f/u 6.1 years 👉No difference in... 5-year disease-free survival (60% v 56%) 5-year overall survival (63% v 59%)

🚨Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer🚨

👏Landmark trial in urology in <a href="/NEJM/">NEJM</a> 

😷592 patients randomized

🗓️Median f/u 6.1 years

👉No difference in...
5-year disease-free survival (60% v 56%)
5-year overall survival (63% v 59%)
European Urology Oncology (@eururoloncol) 's Twitter Profile Photo

The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort by Marco Finati, Matthew Davis et al buff.ly/4gbwN03 #UroSoMe #MedTwitter #ProstateCancer #PCa

The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort by <a href="/FinatiMarco/">Marco Finati</a>, Matthew Davis et al

buff.ly/4gbwN03 

#UroSoMe #MedTwitter #ProstateCancer #PCa
Andrew D. Huberman, Ph.D. (@hubermanlab) 's Twitter Profile Photo

Very interesting study: disrupted gut microbiome in fibromyalgia (mouse & human data) supports the idea that improving gut microbe conditions may help. You can wait for more or just consume 1-3 servings low sugar fermented food daily per other findings cell.com/neuron/fulltex…

UPMC Ireland (@upmcinireland) 's Twitter Profile Photo

UPMC is proud to launch our upgraded PET CT scanner at UPMC Whitfield Hospital—offering faster access & enhanced diagnostic accuracy for patients across Waterford and the South East. Congratulations to our Radiology team for advancing care where it’s needed most.

UPMC is proud to launch our upgraded PET CT scanner at UPMC Whitfield Hospital—offering faster access &amp; enhanced diagnostic accuracy for patients across Waterford and the South East. Congratulations to our Radiology team for advancing care where it’s needed most.
HSE Dublin and South East (@hsedubsoutheast) 's Twitter Profile Photo

On Friday, HSE Ireland published the 2023-2024 Annual Report for Univ Hosp Waterford South East Cancer Services, highlighting the continued focus on providing safe, high-quality care to patients in Waterford, Wexford, South Tipperary and Carlow/Kilkenny.

On Friday, <a href="/HSELive/">HSE Ireland</a> published the 2023-2024 Annual Report for <a href="/UHW_Waterford/">Univ Hosp Waterford</a> South East Cancer Services, highlighting the continued focus on providing safe, high-quality care to patients in Waterford, Wexford, South Tipperary and Carlow/Kilkenny.
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

JUST IN: Tar200 now U.S. FDA approved based on SunRise-1 phase 2 trial in BCG unresponsive NMIBC. -Intravesical form of Gemcitabine - CR: 82.4%/grade ≥3 AE 12.9% - DFS 70.2% at 12m - 51% of CRs with DOR ≥ 12 months.

JUST IN: Tar200 now <a href="/US_FDA/">U.S. FDA</a> approved based on SunRise-1 phase 2 trial in BCG unresponsive NMIBC. 

-Intravesical form of Gemcitabine
- CR: 82.4%/grade ≥3 AE 12.9%
- DFS 70.2% at 12m
- 51% of CRs with DOR ≥ 12 months.